Experimental Therapeutics Program advances cancer therapeutics through innovative clinical research across organ sites. The program emphasizes cancers that are particularly relevant to the Meyer Cancer Center's patient population. In investigating these malignancies, program members focus on:
- Immunotherapy
- Molecular targeted therapies
- Targeting metabolic for therapy
- Early detection and interception